1. How Long-Term Acute Care Hospitals Can Play an Important Role in Controlling Carbapenem-Resistant Enterobacteriaceae in a Region: A Simulation Modeling Study.
- Author
-
Lee, Bruce Y, Bartsch, Sarah M, Lin, Michael Y, Asti, Lindsey, Welling, Joel, Mueller, Leslie E, Leonard, Jim, Brown, Shawn T, Doshi, Kruti, Kemble, Sarah K, Mitgang, Elizabeth A, Weinstein, Robert A, Trick, William E, and Hayden, Mary K
- Subjects
CROSS infection prevention ,HOSPITALS ,INTENSIVE care units ,COST control ,DISEASE prevalence ,DESCRIPTIVE statistics ,CARRIER state (Communicable diseases) ,LONG-term health care - Abstract
Typically, long-term acute care hospitals (LTACHs) have less experience in and incentives to implementing aggressive infection control for drug-resistant organisms such as carbapenem-resistant Enterobacteriaceae (CRE) than acute care hospitals. Decision makers need to understand how implementing control measures in LTACHs can impact CRE spread regionwide. Using our Chicago metropolitan region agent-based model to simulate CRE spread and control, we estimated that a prevention bundle in only LTACHs decreased prevalence by a relative 4.6%–17.1%, averted 1,090–2,795 new carriers, 273–722 infections and 37–87 deaths over 3 years and saved $30.5–$69.1 million, compared with no CRE control measures. When LTACHs and intensive care units intervened, prevalence decreased by a relative 21.2%. Adding LTACHs averted an additional 1,995 carriers, 513 infections, and 62 deaths, and saved $47.6 million beyond implementation in intensive care units alone. Thus, LTACHs may be more important than other acute care settings for controlling CRE, and regional efforts to control drug-resistant organisms should start with LTACHs as a centerpiece. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF